Stock Taper Operating Earnings Per Share (EPS): $1.26, up 45% year-over-year.
Sales Growth: 16 consecutive quarters of sales growth; total new annualized premiums increased by 7%.
Book Value Per Share: $39.92, a 5% increase.
Return on Equity (ROE): 14.1% on a trailing 12-month basis.
Expense Ratio: 18.4%, with expectations for normalization in the latter half of the year.
Shareholder Returns: $77 million returned to shareholders, including $60 million in share repurchases.
Sales Performance: Strong growth across both Consumer and Worksite divisions. Notable records in Medicare Supplement (up 52%) and an increase in annuity collected premiums to $536 million (up 3%).
Agent Growth: Producing agent count increased by 3%, marking the 14th consecutive quarter of growth.
Product Diversification: Emphasis on a broad range of health, wealth, and income protection solutions tailored to customer needs.
Investment Strategy: Continued focus on optimizing the investment portfolio, particularly in corporate bonds, while managing risk.
Revised EPS Guidance: Increased to a range of $4.60 to $4.80 for the full year, reflecting an 8% increase at the midpoint.
Expense Ratio Guidance: Narrowed to 18.8% to 19.0%.
Tax Rate Expectation: Lowered to approximately 21.5%.
Long-term ROE Goals: Aiming to exceed the 12% target previously set for year-end 2027, with intentions to establish new targets in February 2027.
Life Insurance Sales Decline: Life NAP decreased by 9% due to lower direct-to-consumer sales, though the company is adapting its marketing strategy.
Market Competition: Increased competition in the annuity market, although CNO's unique distribution model provides some insulation from competitive pressures.
Consumer NAP Deceleration: Concerns about potential deceleration in consumer NAP growth, particularly as the company faces tougher year-over-year comparisons.
Long-Term Care Margins: Margins have improved, with a reserve release of approximately $4 million noted. Future sustainability of these margins is under review.
Worksite Business Growth: Growth attributed to geographic expansion and improved agent effectiveness, with no major strategic shifts.
Market Dynamics: Discussion on the annuity spread dynamics indicates stable crediting rates, with CNO managing to maintain target spreads despite market pressures.
Capital Deployment: The company remains focused on reinvesting in the business, particularly through the Tech Mod initiative, while also returning capital to shareholders. Overall, CNO Financial Group reported a robust quarter with strong earnings growth and strategic initiatives aimed at sustaining performance, despite facing some competitive pressures and potential challenges in specific product lines.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT